A novel cuproptosis-related gene signature to predict prognosis in Glioma
Abstract Glioma is primary brain tumour with a poor prognosis. Metabolic reprogramming is a hallmark of glioma, and is critical in the development of antiglioma agents and glioma therapy. Cuproptosis is a novel form of cell death mediated by protein lipidation and highly associated with mitochondria...
Main Authors: | Mengyang Zhang, Xiaobai Liu, Di Wang, Xuelei Ruan, Ping Wang, Libo Liu, Yixue Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10714-8 |
Similar Items
-
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
by: Weichen Wang, et al.
Published: (2022-08-01) -
A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
by: HuaXin Zhu, et al.
Published: (2022-12-01) -
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by: Hanwen Lu, et al.
Published: (2022-11-01) -
A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments
by: Di Chen, et al.
Published: (2023-04-01) -
Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
by: Ye Miao, et al.
Published: (2022-09-01)